MEDIVIR AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.05 SEK | -3.79% |
|
-5.86% | +7.02% |
| 04-30 | Transcript : Medivir AB, Q1 2024 Earnings Call, Apr 30, 2024 | |
| 04-30 | Medivir AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Evolution of the average Target Price on Medivir AB
Price target over the last 5 years
History of analyst recommendation changes
8cceb311422780c7.z8eVznBEUyJ-BtGQ67g0qs9bSpxyDpOTS4o4o-qkxF0.nv7C9xoCYFFHR5z3p_5dwpAWGsUoaPzHOfsNk6Llozuqg_GJHQMpdVM1ug~28905f25807446760cdacb3103e7e4f6
Analysts' Consensus
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
3.05
SEK
Average target price
20.62
SEK
Spread / Average Target
+575.96%
High Price Target
54
SEK
Spread / Highest target
+1,670.49%
Low Price Target
8
SEK
Spread / Lowest Target
+162.30%
Consensus detail
Consensus revision (last 18 months)
EPS Revisions
- Stock Market
- Equities
- MVIR B Stock
- Consensus Medivir AB
